A Phase 2 Placebo-Controlled, Randomized, Double Blind, Adaptive Dose Trial of the Safety and Efficacy of Inhaled AZD1419 in Adults With Eosinophilic, Moderate to Severe Asthma
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs AZD 1419 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms INCONTRO
- Sponsors Dynavax Technologies
- 20 Oct 2016 Status changed from not yet recruiting to recruiting.
- 19 Jan 2016 According to Dynavax media release, company is planning to initiate this trial in 2016.
- 10 Dec 2014 New trial record